| Literature DB >> 28371073 |
Bingyang Shi1, Xin Du2, Jian Chen1, Libing Fu3, Marco Morsch3, Albert Lee3, Yong Liu4, Nicholas Cole3, Roger Chung3.
Abstract
Innovative nanoparticles hold promising potential for disease therapy as drug delivery systems. For brain-disease therapy, a drug delivery system that can sustainably control drug-release and monitor fluorescence of the drug cargos is highly desirable. In this study, a light-traceable and intracellular microenvironment-responsive drug delivery system was developed based on the combination of glutathione-responsive autoflurescent nanogel, dendrimer-like mesoporous silica nanoparticles, and gold nanoparticles. The resulting hybrid nanoparticles represent a new class of delivery system that can efficiently load, transport, and control multistage-release of sulfydryl-containing drugs into neurons, with light-traceable monitoring for future brain-disease therapy.Entities:
Keywords: multistage controlled release; neurons; responsive drug delivery; sulfydryl-containing drugs; traceable drug delivery
Mesh:
Substances:
Year: 2017 PMID: 28371073 DOI: 10.1002/smll.201603966
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281